Director TREACE JAMES T bought 84.0K shares at $5.96 on 2024-08-15; holds 1.22M shares post-transaction; stock down 19.0% in 30 days.
Director James T. Treace purchased 84,000 shares for $501.0K at $5.96, expanding his holding to 1.22M shares (+7.4% increase). This buy occurs after a sharp 30-day decline of -19.0%, positioning the purchase near a recent trough relative to the 52-week high of $17.54 (stock now -63.6% from peak). His prior transaction history at TMCI shows two measurable outcomes: buys on 2024-05-13 and 2024-05-10 that delivered +27.6% and +39.5% 90-day returns respectively, both well-timed. Cross-ticker, Treace has executed 5 prior buys with an average 90-day return of +33.5% and a 100% win rate. Against this context, the current purchase at a depressed price follows a pattern of prior successful accumulation at this ticker. However, TMCI remains unprofitable (net income -$21.2M in latest quarter) despite 31.9% annual revenue growth, warranting attention to whether the valuation discount reflects fundamental deterioration or cyclical pressure.